ngµç×ÓÓÎÏ·ÐÂÎÅѶ£¨Í¨Ñ¶Ô±ÌÆÑÞÀö£©¼××´ÏÙÏà¹ØÑÛ²¡£¨TAO£©ÊÇÒ»ÖÖ³£¼ûµÄÃâÒßÑ×Ö¢ÐÔÑÛ¿ô²¡£¬£¬£¬µ«¼¤ËØ¡¢¡¢¡¢ÃâÒßÒÖÖƼÁ¡¢¡¢¡¢ÉúÎïÖƼÁÖÎÁƸ±×÷Óô󣬣¬£¬ngµç×ÓÓÎÏ·ÖÐɽÑÛ¿ÆÖÐÐÄÁºµ¤½ÌÊÚÍŶÓͨ¹ýÑо¿£¬£¬£¬Ê×´ÎÌá³öµÍ¼ÁÁ¿Ç¿Á¦Ã¹ËØÄÜÓÐÓÃÖÎÁÆÇá¶ÈTAO£¬£¬£¬ÕâһЧ¹û½«ÎªÇá¶ÈTAO»¼ÕßÌṩ¾­¼Ã¡¢¡¢¡¢Çå¾²µÄÖÎÁÆ·½°¸£¬£¬£¬Ô츣¿í´óÇá¶ÈTAO»¼Õß¡£

¼××´ÏÙÏà¹ØÑÛ²¡£¨Thyroid-associated Ophthalmopathy, TAO£©ÊÇÒ»ÖÖ³£¼ûµÄÃâÒßÑ×Ö¢ÐÔÑÛ¿ô²¡£¬£¬£¬·¢²¡ÂʾӳÉÈËÑÛ¿ô²¡Ê×λ¡£Ñ×Ö¢ÀÛ¼°ÑÛÍ⼡¡¢¡¢¡¢ÑÛ¿ôÖ¬·¾µÈÈí×éÖ¯£¬£¬£¬µ¼ÖÂÉÏíúÍËËõ¡¢¡¢¡¢ÑÛÇòÍ»³ö¡¢¡¢¡¢ÊÓÎïÖØÓ°µÈÁÙ´²¸Ä±ä£¬£¬£¬ÑÏÖØÕß¿ÉÖÂ䡣ƾ֤¼²²¡ÑÏÖس̶ȿɽ«TAO·ÖΪÇá¶È¡¢¡¢¡¢ÖÐÖضȼ°ÊÓÁ¦ÍþвÐÍ£¬£¬£¬ÆäÖÐÇá¶ÈTAO»¼ÕßÁè¼Ý70%¡£Î·¹â¡¢¡¢¡¢Á÷Àá¡¢¡¢¡¢ÊÓÎïÄ£º£º£ºýÒÔ¼°ÑÛÇòÍ»³ö¡¢¡¢¡¢ÉÏíúÍËËõµÈÐÎ×´¸Ä±äµÈ³ÖÐøÀ§ÈÅÇá¶ÈTAO»¼Õߣ¬£¬£¬ÑÏÖØÓ°Ï컼ÕßµÄÉíÐÄ¿µ½¡¡£±ðµÄ£¬£¬£¬Ô¼80%µÄÇá¶È»¼Õß²¡Çé³ÖÐø»òÏòÖÐÖضÈÏ£Íû£¬£¬£¬ÐèÒªÆð¾¢¾ÙÐиÉÔ¤¡£È»¶ø£¬£¬£¬¼øÓÚ¼¤ËØ¡¢¡¢¡¢ÃâÒßÒÖÖƼÁ¡¢¡¢¡¢ÉúÎïÖƼÁ¸±×÷Óô󣬣¬£¬ÏÖÔÚÖ¸ÄÏÈÔ½¨Òé½ÓÄÉÆÚ´ýÊÓ²ìµÄÖÎÁÆÕ½ÂÔ¡£Òò´Ë£¬£¬£¬Ñ°ÕÒ¸±×÷ÓÃС¡¢¡¢¡¢ÓÐÓõÄÇá¶ÈTAOÖÎÁÆÊֶξßÓÐÖ÷ÒªµÄÁÙ´²ÒâÒå¡£

Ç¿Á¦Ã¹ËØÊÇËÄ»·ËØÀ࿹ÉúËØ¡£¼ÈÍùÎÒÃÇ¿ÎÌâ×éµÄÑо¿·¢Ã÷£¬£¬£¬×ÔÁ¦ÓÚ¿¹¾úЧӦ֮Í⣬£¬£¬µÍ¼ÁÁ¿Ç¿Á¦Ã¹ËؾßÓÐÃâÒßµ÷Àí¹¦Ð§£¬£¬£¬ÄÜÓÐÓÃÖÎÁÆÑÛ±íÃâÒßÑ×Ö¢£¬£¬£¬Í¬Ê±ÓÐÓÃÖÎÁÆÖÐÖضÈTAO¡£ÎÄÏ×Ò²±¨µÀ£¬£¬£¬Ç¿Á¦Ã¹ËØ¿ÉÒÔÓÐÓÃÖÎÁÆ·çʪÐÔÊàŦÑס¢¡¢¡¢ÀàÌìðå´¯¡¢¡¢¡¢¶à·¢ÐÔÓ²»¯µÈ¶àÖÖÃâÒßÑ×Ö¢ÐÔ¼²²¡¡£Îª´Ë£¬£¬£¬ÏîÄ¿×éÆô¶¯ÁËÒ»Ïî¶àÖÐÐÄ¡¢¡¢¡¢Ëæ»ú¡¢¡¢¡¢Ë«Ã¤¡¢¡¢¡¢Î¿½å¼Á±ÈÕÕÁÙ´²Ñо¿£¨RCT£©£¬£¬£¬Ì½Ë÷µÍ¼ÁÁ¿Ç¿Á¦Ã¹ËØÄÜ·ñÓÐÓÃÖÎÁÆÇá¶ÈTAO¡£

¸ÃÑо¿ÓÉÎÒÖÐÐÄÁºµ¤½ÌÊÚǣͷ£¬£¬£¬Ñо¿ÔÚngµç×ÓÓÎÏ·ÖÐɽÑÛ¿ÆÖÐÐÄ¡¢¡¢¡¢ÖÐÄÏ´óѧÏæÑÅÒ½Ôº¡¢¡¢¡¢ÉϺ£½»Í¨´óѧÁ¥ÊôµÚ¾ÅÒ½Ôº¡¢¡¢¡¢±±¾©Ð­ºÍÒ½ÔºÒÔ¼°¸£½¨Ê¡Ê¡Á¢Ò½ÔºµÈÎåÆäÖÐÐÄ¿ªÕ¹£¬£¬£¬¹²ÄÉÈë100ÃûÇкÏÈë×éÌõ¼þµÄÇá¶ÈTAO»¼Õߣ¬£¬£¬ÒÔ1:1µÄ±ÈÀýËæ»ú·ÖÅä¸øÓèÖðÈÕ¿Ú·þ50ºÁ¿ËÇ¿Á¦Ã¹ËØ»òο½å¼Á£¬£¬£¬Á½×é¸÷50Àý»¼Õߣ¬£¬£¬Á¬Ðø·þÓÃ12ÖÜ£¬£¬£¬Í¨¹ý˫äÊÓ²ì½ÏÁ¿Á½Õß»¼Õß12ÖܵĺÃתÂÊ£¬£¬£¬ÆÀ¹ÀÇ¿Á¦Ã¹ËضÔÇá¶ÈTAOµÄÖÎÁÆЧ¹û¡£

Ñо¿Ð§¹ûÅú×¢£º£º£ºÔÚµÚ12ÖÜ£¬£¬£¬Ïà¹ØÓÚο½å¼Á×飬£¬£¬Ç¿Á¦Ã¹ËØÖÎÁÆ×é¾ßÓнϸߵÄÁÙ´²ºÃתÂÊ£¨38% VS 16%£¬£¬£¬ P=0.014£¬£¬£¬¼ûͼ1£©¡£ÕâһЧ¹ûÅú×¢£¬£¬£¬Á¬Ðø12ÖÜÌìÌì¿Ú·þ50mgÇ¿Á¦Ã¹ËØÄܹ»ÓÐÓÃÖÎÁÆÇá¶ÈTAO»¼Õߣ¬£¬£¬¸ÄÉÆÆäÁÙ´²Ö¢×´¡£±ðµÄ£¬£¬£¬±¾Ñо¿»¹Ê״ᨵÀÁËÑÇÖÞÇá¶ÈTAO»¼ÕßµÄ×ÔÈ»ºÃתÂÊ£¬£¬£¬ÕâһЧ¹û¶ÔÁÙ´²Ò½Éú¾öÒéÖÎÁÆ·½°¸¡¢¡¢¡¢¿ªÕ¹Ïà¹ØÑо¿ÌṩÁËÖ÷ÒªÒÀ¾Ý¡£

ͼ1£º£º£ºÑо¿Ð§¹û¼°Æäͳ¼ÆÆÊÎö¡£ÔÚITTÖУ¬£¬£¬½ÓÄÉCochran-Mantel-HaenszelÄ¥Á·£¬£¬£¬ºÃתÂÊΪǿÁ¦Ã¹ËØ×飨38.0%£©VS ο½å¼Á×飨16.0%£©£¬£¬£¬P= 0.01¡£

Ç¿Á¦Ã¹ËØ×÷ΪһÖֹŰåµÄÀÏÒ©£¬£¬£¬ÆäÇå¾²ÐÔÒÑ»ñµÃ³ä·ÖµÄÁÙ´²ÑéÖ¤¡£ÎÒÃÇʹÓõļÁÁ¿ÊÇ¿¹¾ú¼ÁÁ¿(200mg/Ìì)µÄ1/4£¬£¬£¬±¾Ñо¿ÊÓ²ìÁËʹÓÃ3¸öÔµIJ»Á¼·´Ó³¡£ÔÚÇ¿Á¦Ã¹ËØ×éÓÐÒ»Àý»¼Õß·ºÆðÇá¶ÈµÄθ²¿²»ÊÊ£¬£¬£¬ÔÚ·þÓÃÖÊ×Ó±ÃÒÖÖƼÁºóºÃת²¢ÇÒÍê³É12ÖܵÄÒ©Îï¸ÉÔ¤¡£ÕâÅú×¢£¬£¬£¬Á¬Ðø12ÖÜ¿Ú·þµÍ¼ÁÁ¿µÄÇ¿Á¦Ã¹ËؾßÓнϺõÄÇå¾²ÐÔ¡£

ͼ2£º£º£ºÇ¿Á¦Ã¹ËØ×éÒ»Àý»¼Õß°éÓÐÇá¶È賦µÀ²»ÊÊ£¬£¬£¬Í¨¹ý»¤Î¸ÖÎÁÆÍê³ÉºóÐøÑо¿£¬£¬£¬ÌáÐÑÏÔʾǿÁ¦Ã¹ËØÇå¾²ÐÔÓÅÒì¡£

Áºµ¤½ÌÊÚÍŶÓͨ¹ýRCTÑо¿£¬£¬£¬Ê×´ÎÌá³öµÍ¼ÁÁ¿Ç¿Á¦Ã¹ËØÄÜÓÐÓÃÖÎÁÆÇá¶ÈTAO£¬£¬£¬ÕâһЧ¹û½«ÎªÇá¶ÈTAO»¼ÕßÌṩÁËÇå¾²µÄÖÎÁÆ·½°¸¡£Ç¿Á¦Ã¹ËؼÛÇ®×ÔÖÆ£¬£¬£¬Äܱ»¿í´ó»¼ÕßËù½ÓÊÜ£¬£¬£¬ÕâÖÖеÄÖÎÁÆ·½°¸±Ø½«Ô츣Çá¶ÈTAO»¼Õß¡£Î´À´£¬£¬£¬ÍŶӻ¹½«ÔÚ±¾¿ÎÌâµÄ»ù´¡ÉÏ£¬£¬£¬¿ªÕ¹½øÒ»²½µÄÁÙ´²Ñо¿£¬£¬£¬ÊÓ²ìÌá¸ßÇ¿Á¦Ã¹ËؼÁÁ¿ºÍ/»òÑÓÉìÖÎÁÆʱ¼äÄÜ·ñ½øÒ»²½Ìá¸ßÁÆЧ¡£

ÖµµÃÒ»ÌáµÄÊÇ£¬£¬£¬¸ÃÑо¿»¹»ñµÃÁËÔÓÖ¾µÄͬÆÚÊöÆÀ£¬£¬£¬ÆÀ¼ÛÆ𾢿͹Û£¬£¬£¬ÍâÑóÙÉÐгä·Ö¿Ï¶¨Á˸ÃÑо¿µÄ¿Æѧ¼ÛÖµºÍÉîÔ¶µÄÁÙ´²ÒâÒå¡£

ÒÔÉÏÑо¿Ð§¹ûÓÚ2022Äê9ÔÂ29ÈÕ½ÒÏþÓÚJAMA Ophthalmology¡£ngµç×ÓÓÎÏ·ÖÐɽÑÛ¿ÆÖÐÐÄÁºµ¤½ÌÊÚΪͨѶ×÷Õߣ¬£¬£¬ÅËæ¡¢¡¢¡¢³ÂخϪ¡¢¡¢¡¢ÕŽ¨¡¢¡¢¡¢ÁÖÃîÀö¡¢¡¢¡¢Áõ×Æ˸ΪÅäºÏµÚÒ»×÷Õß¡£ngµç×ÓÓÎÏ·ÖÐɽÑÛ¿ÆÖÐÐÄ¡¢¡¢¡¢ÑÛ¿Æѧ¹ú¼ÒÖصãʵÑéÊÒΪµÚÒ»µ¥Î»£¬£¬£¬ÖÐÄÏ´óѧÏæÑÅÒ½Ôº¡¢¡¢¡¢ÉϺ£½»Í¨´óѧÁ¥ÊôµÚ¾ÅÒ½Ôº¡¢¡¢¡¢±±¾©Ð­ºÍÒ½ÔºÒÔ¼°¸£½¨Ê¡Ê¡Á¢Ò½ÔºÎªÏàÖúµ¥Î»¡£

ÂÛÎÄÁ´½Ó£º£º£º

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2796841

ͬÆÚÊöÆÀÁ´½Ó£º£º£º

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2796845